Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease

Digestion

Volumn 79, Issue 3, 2009, Pages 186-195

  Mönkemüller, Klaus ^a   Wex, Thomas ^a   Kuester, Doerthe ^a   Fry, Lucia C ^a   Peitz, Ulrich ^a   Beyer, Mike ^a   Roessner, Albert ^a   Malfertheiner, Peter ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Gastroesophageal reflux disease; Histology; Inflammation; Interleukin, cytokines; Non erosive gastroesophageal reflux disease

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; INTERCELLULAR SPACE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 63349108117     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000211714     Document Type: Article

References (40)

1. Locke GR III, Talley NJ, Fett SL, et al: Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead county, Minnesota. Gastroenterology 1997;112:1448-11156
2. Stanghellini V: Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999;231:29-37.
3. Vakil N, van Zanten SV, Kahriks P, Dent J, Jones R: Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence- based consensus. Am J Gastroenterol 2006; 101:1900-1920.
4. Pass R: Distinct phenotypic presentations of gastroesophageal reflux disease: a new view of the natural history. Dig Dis 2004;22:100-107.
5. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Kongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
6. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Mar- gulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: The endoscopic assessment of eso- phagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
7. Labenz I, Jaspersen D, Kullig M, Leodolter A, Lind T, Meyer-Sabelek W, Stolte M, Vieth M, Willich S, Malfertheiner P: Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652-1656.
8. DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastro- oesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999;94:1434-1442.
9. Chey WD: Endoscopy negative reflux disease: concepts and clinical practice. Am J Med 2004;117:36-43.
10. Bove M, Vieth M, Dombrowski F, Ny L, Ruth M, Lundell L: Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease. Dig Dis Sci 2005;50:1488-1496.
11. Vieth M, Fiocca R, Haringsma J, Delarive J, Wiesel P, Tam W, Tytgat G, Dent J, Edebo A, Lundell L, Stolte M: Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesions. Dig Dis 2004;22:208-212.
12. Ismail-Beigi F, Horton PF, Pope CE: Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-174.
13. Chandrasoma PT, Lokuhetty DM, De- meester TR, Bremmer CG, Peters JH, Oberg S, Groshen S: Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 2000;24:344-351. (Pubitemid 30127469)
14. Isomoto H, Saenko VA, Kanazawa Y, Nishi Y, Ohtsuru A, Inoue K, Akazawa Y, Takeshi- ma F, Omagari K, Miyazaki M, Mizuta Y, Murata I, Yamashita S, Kohno S: Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-nega- tive gastroesophageal reflux disease. Am J Gastroenterol 2004;99:589-597. (Pubitemid 38607958)
15. Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase M, Hayashi T, Inoue K, Murata I, Kohno S: Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003;98:551-556.
16. 16 Fujiwara Y, Higuchi K, Hamaguchi M, Ta- kashima T, Watanabe T, Tominaga K, Oshi- tani N, Matsumoto T, Arakawa T: Increased expression of transforming growth factor- alpha and epidermal growth factor receptors in rat chronic reflux esophagitis. J Gastroenterol Hepatol 2004;19:521-527. (Pubitemid 38669899)
17. Yamaguchi T, Yoshida N, Tomatsuri N, Takayama R, Katada K, Takagi T, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T: Cyto- kine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int J Mol Med 2005;16:71-77.
18. 18 Hamaguchi M, Fujiwara Y, Takashima T, Hayakawa T, Sasaki E, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Hi- guchi K, Arakawa T: Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003;68:189-197. (Pubitemid 38250508)
19. Nocon M, Kulig M, Leodolter A, et al: Validation of the Reflux Disease Questionnaire for a German population. Eur J Gastroenterol Hepatol 2005;17:229-233.
20. Dixon MF, Genta RM, Yardley JH, et al: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
21. 21 Wex T, Treiber G, Lendeckel U, Malferthei- ner PA: Two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin Chem Lab Med 2003;41:1033-1037. (Pubitemid 37062994)
22. O'Riordan JM, Abdel-latif MM, Ravi N, Mc- Namara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV: Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metapla- sia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005; 100:1257-1264.
23. Abdalla SI, Sanderson IR, Fitzgerald RC: Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. Carcinogenesis 2005; 26:1627-1633.
24. Kanazawa Y, Isomoto H, Wen CY, Wang AP, Saenko VA, Ohtsuru A, Takeshima F, Omagari K, Mizuta Y, Murata I, Yamashita S, Kohno S: Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non- erosive reflux disease. World J Gastroenterol 2003;9:2801-2804.
25. Isomoto H, Kanazawa Y, Nishi Y, Wen CY, Inoue K, Kohno S: Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis. World J Gastroenterol 2005;11:1793-1797.
26. 26 Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G, Ray M, Katz JA, Ca- tanzaro A, O'Shea R, Post AB, Wong R, Sivak MV, McCormick T, Phillips M, West GA, Willis JE, Biancani P, Fiocchi C: Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine producion leading to motor abnormalities. Gastroenterology 2007; 132:154-165. (Pubitemid 46108733)
27. Wallace JL, Cucala M, Mugridge K, et al: Se- cretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 261:G559-G564.
28. Queiroz DM, Guerra JB, Rocha GA, et al: IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux oesophagitis. Gastroenterology 2004;127:73-79.
29. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H: Interleukin IB proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006; 55: 158-164.
30. Arend WP, Palmer G, Gabay C: IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38.
31. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM: Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998:66:5964-5971.
32. Compton CC, Warland G, Nakagawa H, Opitz OG, Rustgi AK: Cellular characterization and successful transfection of serially subcultured normal human esophageal ke- ratinocytes. J Cell Physiol 1998; 177:274-281.
33. Isomoto H, Wang A, Nishi Y, Matsumoto A, Shikuwa S, Mizuta Y, Inoue K, Kohno S: In- terleukin 8 and lbeta and RANTES levels in esophageal mucosa predict recurrence of en- doscopy-negative gastroesophageal reflux disease. Hepatogastroenterology 2008; 55: 482-485.
34. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ: There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther 2002;16:735-742.
35. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley N J, Agraus L: High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275-285.
36. 36 Tobey NA, Hosseini SS, Argote CM, Dobru- cali AM, Awayda MS, Orlando RC: Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004;99:13-22. (Pubitemid 38679095)
37. Calabrese C, Bortolotti M, Fabbri A, Areni A, Cenacchi G, Scialpi C, Miglioli M, Di Febo G: Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 2005;100:537-542.
38. Neumann H, Monkemiiller K, Beyer M, Dombrowski F, Fry LC, Malfertheiner P: Dilated intercellular spaces of esophageal epithelium in non-erosive and erosive reflux disease patients and appropriate controls. Gut 2007;56:A206.
39. Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MP, Petitti T, Cicala M: Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;25:629-636.
40. Bhat YM, Bielefeldt K: Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol 2006;18:263-270.